Showing 3221-3230 of 5063 results for "".
Avoid Financial Gridlock when Partners Disagree
https://practicaldermatology.com/topics/practice-management/avoid-financial-gridlock-when-partners-disagree/20980/Three ideas for every group practice.Currents
https://practicaldermatology.com/topics/practice-management/currents/21012/Recent Developments
https://practicaldermatology.com/columns/recent-developments/PD0409_05-php/22843/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-6/23116/Setting Things Right
https://practicaldermatology.com/issues/supplements/setting-things-right/23412/Understanding the Role of Balneotherapy in Treating Moderate to Severe Atopic DermatitisManage and Prevent Isotretinoin Side Effects
https://practicaldermatology.com/topics/general-topics/PD0409_01-php/22839/This guide will help you anticipate and prevent or minimize side effects that your patients can develop as a result of isotretinoin therapy.Home-Use Laser and Light Devices: Just What the Doctor Ordered
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/home-use-laser-and-light-devices-just-what-the-doctor-ordered/23335/Laser and light-based devices are more at home than ever as lightweight LEDs, wearable technology, and “smart” apps support adherence and enhance efficacy.EHR Use in Dermatology: Where We Stand
https://practicaldermatology.com/topics/practice-management/ehr-use-in-dermatology-where-we-stand/21624/CMS released data for EHR use in 2011, but next year's data will likely determine the role EHRs will play in the future of dermatology.The Landscape for Vitiligo: An Interview with Larry Green, MD
https://practicaldermatology.com/topics/pigmentary-disorders/the-landscape-for-vitiligo-an-interview-with-larry-green-md/24209/Practical Dermatology® Chief Medical Editor Neal Bhatia, MD, FAAD, talked with Larry Green, MD, a board-certified dermatologist in private practice in Rockville, Maryland, about the latest in vitiligo treatment and what practitioners can tell their patients about recent advances in treatment for thiSecond Primary Tumors and Immune Checkpoint Inhibitors: What Do We Know?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/second-primary-tumors-and-immune-checkpoint-inhibitors-what-do-we-know/23452/New evidence reveals a potential link between ICI treatment and risk for secondary cancers.